Materials & Resources » Mining, Metals & Minerals | Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc. | Income Statement

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
112.50
5.70
9.60
Cost of Goods Sold (COGS) incl. D&A
-
0.10
1.30
-
7.00
-
Gross Income
-
0.10
1.30
-
1.30
-
SG&A Expense
57.90
215.10
535.20
391.60
1,852.60
3,729.90
EBIT
57.90
215.20
536.50
280.70
1,853.90
3,808.70
Unusual Expense
-
-
-
-
64.70
64.90
Non Operating Income/Expense
1.70
3.00
4.90
1.40
10.90
32.80
Interest Expense
0.20
1.00
-
27.20
4.40
-
Pretax Income
56.40
219.10
541.40
307.20
1,933.80
3,776.60
Consolidated Net Income
56.40
219.10
541.40
307.20
1,933.80
3,776.60
Net Income
56.40
219.10
541.40
307.20
1,933.80
3,776.60
Net Income After Extraordinaries
56.40
168.30
541.40
307.20
1,933.80
3,776.60
Net Income Available to Common
56.40
270.00
541.40
307.20
1,933.80
3,776.60
EPS (Basic)
0.04
0.01
0.01
0.00
0.02
0.03
Basic Shares Outstanding
1,360.40
51,632.40
100,706.90
103,258.50
110,380.40
120,377.70
EPS (Diluted)
0.04
0.01
0.01
0.00
0.02
0.03
Diluted Shares Outstanding
1,360.40
51,632.40
100,706.90
103,258.50
110,380.40
120,377.70
EBITDA
57.90
215.10
535.20
279.10
1,846.90
3,720.30

About Cannabics Pharmaceuticals

View Profile
Address
No. 3 Bethesda Metro Center
Bethesda Maryland 20814
United States
Employees -
Website http://www.cannabics.com
Updated 07/08/2019
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.